A team of three professors, two from UMCP and one from UMB, were selected to host the nation’s Principal Investigators Meeting of the Materials Genome Initiative (MGI) on March
Tri-specific antibody targets and neutralizes 99.5% of HIV-1 virus strains
A team of researchers at IBBR, led by Dr. Yuxing Li, Associate Professor at the University of Maryland School of Medicine, Baltimore, and Principal Investigator at the Institute for Bioscience and Biotechnology Research (IBBR), Rockville, is showing how engineered multi-specific antibodies appear to be highly effective at preventing infection across a broad range of HIV-1 virus strains.
The Division of Research has announced the nominees for the Invention of the Year Award. For 2017, there were over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history totaling $219.5 million from the A. James and Alice B. Clark Foundation.
UMD researchers work to defend poplar trees – a promising resource for renewable and sustainable energy – from leaf rust and other diseases
The new year is off to a great start for the partnership between University of Maryland (UMD) and Shanghai’s East China University of Science and Technology (ECUST). This partnership began five years ago when Prof.
Sarah Gao to Compete for Top Awards in Most Prestigious U.S. Science and Mathematics Competition for High School Seniors
Over $3M in Regeneron Science Talent Search Awards Will Be Distributed in 2018
New approaches hope to give researchers a glimpse into the cell’s “alert system” to fight tumors and viruses
The goal is to develop and test a “first-in-class multi-specific antibody“, which could offer dramatic advantages over current treatments for AIDS patients, help eliminate hidden reservoirs of HIV, and potentially deliver on the promise of a long-awaited HIV cure.
Local students complete a biotechnology summer internship program and present their research projects in a poster session.